These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3280188)

  • 1. The initiation and early development of autoimmune diseases.
    Ada GL; Rose NR
    Clin Immunol Immunopathol; 1988 Apr; 47(1):3-9. PubMed ID: 3280188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the MHC in autoimmunity: an overview.
    Mellins ED
    J Rheumatol Suppl; 1992 Apr; 33():63-9. PubMed ID: 1593605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.
    Nossal GJ; Herold KC; Goodnow CC
    Diabetologia; 1992 Dec; 35 Suppl 2():S49-59. PubMed ID: 1478378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible role of histamine in pathogenesis of autoimmune diseases: implications for immunotherapy with histamine-2 receptor antagonists.
    Nielsen HJ; Hammer JH
    Med Hypotheses; 1992 Dec; 39(4):349-55. PubMed ID: 1362972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis.
    Smith SC; Allen PM
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9131-5. PubMed ID: 1409614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression level of risk genes of MHC class II is a susceptibility factor for autoimmunity: New insights.
    Gianfrani C; Pisapia L; Picascia S; Strazzullo M; Del Pozzo G
    J Autoimmun; 2018 May; 89():1-10. PubMed ID: 29331322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetics of autoimmune-mediated rheumatic diseases: clinical and biologic implications.
    Winchester R
    Rheum Dis Clin North Am; 2004 Feb; 30(1):213-27, viii. PubMed ID: 15061576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
    Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
    J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation for autoimmune diseases.
    Ikehara S
    Acta Haematol; 1998; 99(3):116-32. PubMed ID: 9587393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class II major histocompatibility complex and organ specific autoimmunity in man.
    Foulis AK
    J Pathol; 1986 Sep; 150(1):5-11. PubMed ID: 2946837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen presentation and self-nonself discrimination.
    Adorini L
    Clin Immunol Immunopathol; 1990 Jun; 55(3):327-36. PubMed ID: 1971200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes.
    Wicker LS; Appel MC; Dotta F; Pressey A; Miller BJ; DeLarato NH; Fischer PA; Boltz RC; Peterson LB
    J Exp Med; 1992 Jul; 176(1):67-77. PubMed ID: 1613467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of self-reactive T cell receptor V beta regions in autoimmune mice.
    Mountz JD; Smith TM; Toth KS
    J Immunol; 1990 Mar; 144(6):2159-66. PubMed ID: 1690237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC-derived peptides and the CD4+ T-cell repertoire: implications for autoimmune disease.
    Baum H; Staines NA
    Cytokines Cell Mol Ther; 1997 Jun; 3(2):115-25. PubMed ID: 9287250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological autoimmune disease and the trimolecular complex of T-lymphocytes.
    Hohlfeld R
    Ann Neurol; 1989 Jun; 25(6):531-8. PubMed ID: 2662895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The current outlook in the therapy of autoimmune diseases].
    Sebastiani GD; Passiu G
    Ann Ital Med Int; 1992; 7(2):95-101. PubMed ID: 1467130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid variations at a single residue in an autoimmune peptide profoundly affect its properties: T-cell activation, major histocompatibility complex binding, and ability to block experimental allergic encephalomyelitis.
    Kumar V; Urban JL; Horvath SJ; Hood L
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1337-41. PubMed ID: 1689484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.